["{\n\"step_by_step_thinking\": \"The question asks to identify which option is NOT a GP IIb/IIIa inhibitor. The provided documents are unrelated to the question. Therefore, I will rely on external knowledge and the relevant medical literature to answer this question.\\r\\n\\r\\nAccording to external sources, Prasugrel is an orally active P2Y12 receptor antagonist that inhibits platelet aggregation by blocking the action of adenosine diphosphate (ADP) on platelet receptors. It is used to treat acute coronary syndromes.\\r\\n\\r\\nGP IIb/IIIa inhibitors are a class of medications that prevent blood clots from forming. Abciximab, Tirofiban, and Eptifibatide are all GP IIb/IIIa inhibitors.\\r\\n\\r\\nTherefore, based on external knowledge, Prasugrel is the only option that is NOT a GP IIb/IIIa inhibitor.\",\n\"answer_choice\": \"A\"\n}"]